14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $16.60 $18.63 Tuesday, 23rd Apr 2024 ACAD stock ended at $16.74. This is 1.47% less than the trading day before Monday, 22nd Apr 2024. During the day the stock fluctuated 3.76% from a day low at $16.61 to a day high of $17.23.
90 days $16.60 $29.29
52 weeks $16.60 $33.91

Historical ACADIA Pharmaceuticals Inc. prices

Date Open High Low Close Volume
Jul 12, 2021 $23.68 $23.80 $23.30 $23.74 1 048 528
Jul 09, 2021 $23.70 $23.95 $23.16 $23.71 817 087
Jul 08, 2021 $23.64 $24.26 $23.47 $23.70 950 551
Jul 07, 2021 $24.20 $24.20 $23.52 $23.97 924 009
Jul 06, 2021 $24.39 $24.76 $24.02 $24.13 1 050 908
Jul 02, 2021 $24.73 $24.77 $24.05 $24.30 1 129 277
Jul 01, 2021 $24.22 $24.77 $23.93 $24.77 1 054 031
Jun 30, 2021 $24.25 $25.19 $23.75 $24.39 2 343 378
Jun 29, 2021 $25.36 $25.36 $23.83 $24.13 1 445 480
Jun 28, 2021 $26.15 $26.18 $24.95 $25.33 1 521 330
Jun 25, 2021 $24.97 $26.32 $24.61 $26.17 14 061 401
Jun 24, 2021 $24.55 $25.57 $24.48 $25.01 1 459 854
Jun 23, 2021 $25.02 $25.02 $24.07 $24.52 1 204 709
Jun 22, 2021 $24.96 $25.09 $24.47 $24.88 1 233 048
Jun 21, 2021 $26.00 $26.01 $24.94 $25.01 1 757 687
Jun 18, 2021 $25.79 $26.23 $25.24 $26.03 2 640 416
Jun 17, 2021 $25.83 $26.50 $25.42 $25.85 1 015 606
Jun 16, 2021 $26.31 $26.72 $25.46 $25.90 1 565 584
Jun 15, 2021 $27.07 $27.10 $26.04 $26.27 1 471 483
Jun 14, 2021 $27.36 $27.68 $26.86 $27.24 1 442 371
Jun 11, 2021 $27.09 $27.60 $26.91 $27.42 1 193 897
Jun 10, 2021 $25.95 $27.34 $25.70 $27.30 1 681 508
Jun 09, 2021 $26.73 $27.06 $25.62 $26.13 1 763 374
Jun 08, 2021 $25.40 $26.63 $25.24 $26.57 1 982 973
Jun 07, 2021 $23.72 $26.05 $23.65 $25.40 3 782 629
Click to get the best stock tips daily for free!

About ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals. ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's pipeline include, pimavanserin, under phase 3 development for the treatment of Alzheimer's disease psych... ACAD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT